Rebuilding my body: Breast reconstruction in England – Breast Cancer Now

Research from Breast Cancer Now into the availability of breast reconstruction surgery, that finds some Clinical Commissioning Groups (CCGs) in England are restricting access to this surgery. Since 2012, 22.6% of CCGs have introduced official policies restricting breast reconstruction surgery while a further 4.3% have policies that are either informal

Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma: Technology appraisal guidance [TA524] – NICE

Evidence-based recommendations on brentuximab vedotin (Adcetris) for treating CD30-positive Hodgkin lymphoma in adults. This guidance is a Cancer Drugs Fund reconsideration of brentuximab vedotin for treating CD30-positive Hodgkin lymphoma (TA446). This guidance replaces TA446.  

Arsenic trioxide for treating acute promyelocytic leukaemia: Technology appraisal guidance [TA526] – NICE

Evidence-based recommendations on arsenic trioxide (Trisenox) for treating acute promyelocytic leukaemia in adults.  

Midostaurin for untreated acute myeloid leukaemia: Technology appraisal guidance [TA523] – NICE

Evidence-based recommendations on midostaurin (Rydapt) for untreated FLT3-mutation-positive acute myeloid leukaemia in adults.

Screening Quality Assurance visit report: NHS Cervical Screening Programme East Lancashire Hospitals NHS Trust – Public Health England

Finds the service is well organised with the lead colposcopist providing strong leadership. Team members are engaged and motivated. A systematic and focused approach to quality improvement was evident with engagement in activities to reduce health inequalities and improve community engagement to

Patient access to ibrutinib for previously treated chronic lymphocytic leukaemia in England – NHS England

This clinical statement gives details about patient access to ibrutinib for chronic lymphocytic leukaemia. It states NHS is funding the cancer drug in line with NICE recommendations.

National Dose Banding Table – Ipilimumab 5mgmL – NHS England

The national dose banding tables are to be used by hospital trust pharmacy teams to ensure a standard approach to dose banding of chemotherapy across all hospital trusts.

National Dose Banding Table – Capecitabine – NHS England

The national dose banding tables are to be used by hospital trust pharmacy teams to ensure a standard approach to dose banding of chemotherapy across all hospital trusts.

Screening Quality Assurance visit report: Basildon and Thurrock Hospitals NHS Foundation Trust Cervical Screening Programme – Public Health England

Executive summary of quality assurance (QA) visit to Basildon and Thurrock Hospitals NHS Foundation Trust held on 27 June 2017. The QA visit team identified 30 high priority findings. These have been summarised below: there is a lack of documentation detailing the requirements

Screening Quality Assurance visit report: NHS Cervical Screening Programme Lancashire Teaching Hospitals NHS Foundation Trust – Public Health England

Executive summary of quality assurance (QA) visit to Lancashire Teaching Hospitals NHS Foundation Trust held on 28 and 29 June 2017. The QA visit team identified 8 high priority findings as summarised below: ensure that the hospital based programme co-ordinator (HBPC) role

Screening Quality Assurance interim visit report: NHS Cervical Screening Programme York Teaching Hospital NHS Foundation Trust – Cytology Service – Public Health England

Executive summary of quality assurance (QA) visit to York Teaching Hospital NHS Trust held on 10 October 2017. The QA visit team identified no high priority findings. However, summarised below are key themes: laboratory workforce protocol revision

Screening Quality Assurance visit report: NHS Breast Screening Programme Crewe Breast Screening Service – Public Health England

Executive summary of quality assurance (QA) visit to Crewe Breast Screening Service held on 28 September 2017. Finds major staffing shortages across radiology, pathology and some vacancies in surgery and radiography making the service extremely vulnerable. The current team works exceptionally hard to deliver

Missed Opportunities: Advance Care Planning Report – Macmillan Cancer Support

Macmillan Cancer Support report looking at Advance Care Planning (ACP) – or Anticipatory Care Planning in Scotland.  A term used to describe conversations between a person and those involved in their care about their future wishes and care preferences. A person who is

Screening Quality Assurance visit report: NHS Cervical Screening Programme Frimley Health NHS Foundation Trust – Public Health England

Executive summary of quality assurance (QA) visit to Frimley Health NHS Foundation Trust held on 9, 19 and 20 June 2017. The QA visit team identified 2 immediate concerns which were addressed within seven days of the visit. all colposcopy examinations must

Screening Quality Assurance visit report: NHS Bowel Cancer Screening Programme Leicester Bowel Screening Centre – Public Health England

Executive summary of quality assurance (QA) visit to Leicester Bowel Screening Centre on 23 March 2017.  The QA visit team identified one immediate concern: ensure that all transfer of confidential electronic patient identifiable data between hospital sites is secure (this has been confirmed

Screening Quality Assurance visit report: NHS Bowel Cancer Screening Programme South Yorkshire and Bassetlaw Bowel Cancer Screening Service – Public Health England

Executive summary of quality assurance (QA) visit to South Yorkshire and Bassetlaw held on 28 and 29 September 2017. The QA visit team identified 3 high priority findings as summarised below: there are some significant staffing issues within pathology there is

Screening Quality Assurance visit report: NHS Cervical Screening Programme Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust – Public Health England

Executive summary of quality assurance (QA) visit to Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust held on 05 July 2017.  The QA visit team identified 9 high priority findings as summarised below: ensure the hospital based programme co-ordinator (HBPC) has

Cancer workforce in England: A census of cancer, palliative and chemotherapy speciality nurses and support workers in England in 2017 – Macmillan Cancer Support

Macmillan Cancer Support report revealing broad variations in the ratio of patients to specialist cancer nurses and warns that such wide variation may mean that patients may not be getting access to badly-needed specialist care. While the workforce as a whole has